Emergency Anticoagulation Reversal with Idarucizumab

Professor Peter Verhamme (Associate Professor in the Department of Cardiovascular Sciences, Center for Vascular and Molecular Biology, University of Leuven, Belgium) discusses a clinical case where the specific reversal agent idarucizumab (Praxbind^®) was used for emergency reversal of dabigatran (Pradaxa^®).